Michael C. Cavalier

416 total citations
15 papers, 320 citations indexed

About

Michael C. Cavalier is a scholar working on Molecular Biology, Computational Theory and Mathematics and Biochemistry. According to data from OpenAlex, Michael C. Cavalier has authored 15 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Computational Theory and Mathematics and 3 papers in Biochemistry. Recurrent topics in Michael C. Cavalier's work include Computational Drug Discovery Methods (5 papers), S100 Proteins and Annexins (5 papers) and Antioxidant Activity and Oxidative Stress (3 papers). Michael C. Cavalier is often cited by papers focused on Computational Drug Discovery Methods (5 papers), S100 Proteins and Annexins (5 papers) and Antioxidant Activity and Oxidative Stress (3 papers). Michael C. Cavalier collaborates with scholars based in United States and South Korea. Michael C. Cavalier's co-authors include David J. Weber, David B. Neau, Oliver B. Clarke, Yunting Chen, Lawrence Shapiro, William S. Blaner, Raquel Godoy‐Ruiz, Paul T. Wilder, M. Chiara Manzini and Youn‐Kyung Kim and has published in prestigious journals such as Science, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Michael C. Cavalier

14 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael C. Cavalier United States	9	234	41	37	32	26	15	320
Ashraf Dar India	14	379 1.6×	17 0.4×	26 0.7×	49 1.5×	19 0.7×	19	515
Sunil K. Verma United States	12	353 1.5×	21 0.5×	76 2.1×	25 0.8×	5 0.2×	18	481
Dachuan Cai China	10	143 0.6×	11 0.3×	81 2.2×	32 1.0×	8 0.3×	34	437
K. Muniyappa India	10	191 0.8×	8 0.2×	40 1.1×	15 0.5×	6 0.2×	17	347
Shahnawaz Ali India	11	223 1.0×	5 0.1×	44 1.2×	24 0.8×	31 1.2×	25	333
Binghua Shen United States	10	403 1.7×	50 1.2×	11 0.3×	8 0.3×	4 0.2×	13	502
Jason van Rooyen South Africa	8	206 0.9×	4 0.1×	12 0.3×	29 0.9×	27 1.0×	15	338
Vincent Cura France	14	713 3.0×	6 0.1×	17 0.5×	23 0.7×	31 1.2×	26	881
Olayiwola A. Adekoya Norway	11	242 1.0×	5 0.1×	8 0.2×	48 1.5×	28 1.1×	19	350
Kendra R. Vann United States	12	310 1.3×	6 0.1×	33 0.9×	13 0.4×	8 0.3×	20	387

Countries citing papers authored by Michael C. Cavalier

Since Specialization

Citations

This map shows the geographic impact of Michael C. Cavalier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Cavalier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Cavalier more than expected).

Fields of papers citing papers by Michael C. Cavalier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Cavalier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Cavalier. The network helps show where Michael C. Cavalier may publish in the future.

Co-authorship network of co-authors of Michael C. Cavalier

This figure shows the co-authorship network connecting the top 25 collaborators of Michael C. Cavalier. A scholar is included among the top collaborators of Michael C. Cavalier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael C. Cavalier. Michael C. Cavalier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Terry, Alexander R., Michael C. Cavalier, Kaylin A. Adipietro, et al.. (2021). The calcium-binding protein S100B reduces IL6 production in malignant melanoma via inhibition of RSK cellular signaling. PLoS ONE. 16(8). e0256238–e0256238. 2 indexed citations

Varshney, Avanish K., Jian Lin, Yanfeng Zhang, et al.. (2018). A natural human monoclonal antibody targeting Staphylococcus Protein A protects against Staphylococcus aureus bacteremia. PLoS ONE. 13(1). e0190537–e0190537. 62 indexed citations

Cavalier, Michael C., Zephan Melville, E. Prabhu Raman, et al.. (2016). Novel protein–inhibitor interactions in site 3 of Ca²⁺-bound S100B as discovered by X-ray crystallography. Acta Crystallographica Section D Structural Biology. 72(6). 753–760. 11 indexed citations

Chen, Yunting, Oliver B. Clarke, Jonathan Kim, et al.. (2016). Structure of the STRA6 receptor for retinol uptake. Science. 353(6302). 112 indexed citations

Cavalier, Michael C., Mohd. Imran Ansari, Paul T. Wilder, et al.. (2016). Small Molecule Inhibitors of Ca²⁺-S100B Reveal Two Protein Conformations. Journal of Medicinal Chemistry. 59(2). 592–608. 15 indexed citations

Cavalier, Michael C. & David J. Weber. (2015). Targeting Melanoma with Small Molecules: Inhibitors of the Calcium-Binding Protein S100B. Biophysical Journal. 108(2). 214a–214a.

Lanning, Maryanna E., Paul T. Wilder, Michael C. Cavalier, et al.. (2015). Towards more drug-like proteomimetics: two-faced, synthetic α-helix mimetics based on a purine scaffold. Organic & Biomolecular Chemistry. 13(32). 8642–8646. 16 indexed citations

Cavalier, Michael C., Paul T. Wilder, David B. Neau, et al.. (2014). Covalent Small Molecule Inhibitors of Ca²⁺-Bound S100B. Biochemistry. 53(42). 6628–6640. 34 indexed citations

Cavalier, Michael C., Young‐Sun Yim, Shumpei Asamizu, et al.. (2012). Mechanistic Insights into Validoxylamine A 7'-Phosphate Synthesis by VldE Using the Structure of the Entire Product Complex. PLoS ONE. 7(9). e44934–e44934. 15 indexed citations

10.

Cavalier, Michael C., et al.. (2011). Investigating combinatorial approaches in virtual screening on human inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3): A case study for small molecule kinases. Analytical Biochemistry. 418(1). 143–148. 4 indexed citations

11.

Cavalier, Michael C., et al.. (2011). Molecular basis of the fructose‐2,6‐bisphosphatase reaction of PFKFB3: Transition state and the C‐terminal function. Proteins Structure Function and Bioinformatics. 80(4). 1143–1153. 21 indexed citations

12.

Cavalier, Michael C., et al.. (2007). A Direct Substrate–Substrate Interaction Found in the Kinase Domain of the Bifunctional Enzyme, 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase. Journal of Molecular Biology. 370(1). 14–26. 12 indexed citations

13.

Menelaou, Evdokia, et al.. (2006). Lutein Content in Sweetpotato Leaves. HortScience. 41(5). 1269–1271. 7 indexed citations

14.

Cavalier, Michael C., et al.. (2006). (268) Lutein Content in Sweetpotato Leaves. HortScience. 41(4). 1027C–1027. 7 indexed citations

15.

Cavalier, Michael C.. (1976). Early neoplastic change related to a denture identification mark. BDJ. 140(1). 23–24. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact